Related Experiment Video
Updated: Jan 27, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Suspected hematologic malignancy complicates lupus cerebritis treatment
1Morgan Walgren practices at Nebraska Medicine Immediate Care Clinics and is a medical student at the University of Nebraska Medical Center, both in Omaha, Neb. The author has disclosed no potential conflicts of interest, financial or otherwise.
Insights
Systemic lupus erythematosus (SLE) can present as lupus cerebritis, a condition affecting the brain. Managing SLE with comorbidities, like malignancy risk, requires careful treatment decisions to balance benefits and harm.
Area of Science:
- Neuroscience
- Rheumatology
- Oncology
Background:
- Comorbidities complicate treatment planning for complex diseases.
- Systemic lupus erythematosus (SLE) is an autoimmune condition with diverse manifestations.
- Neuropsychiatric involvement, such as lupus cerebritis, presents unique clinical challenges.
Abstract:
Comorbidities make determining a patient's optimal treatment plan substantially more difficult. This article describes lupus cerebritis, a neuropsychiatric presentation of systemic lupus erythematosus, in a patient with a risk for hematologic malignancies. The patient's primary care team had to weigh the benefit versus potential harm of various therapies to find the best treatment.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Pneumonia III: Complications and Assessment
Hemodialysis II: Procedure and Complications
Asthma-III: Symptoms and Complications
Classification of Asthma
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Cerebral Hemispheres

